Propranolol Inhibits EMT and Metastasis in Breast Cancer through miR-499-5p-Mediated Sox6

Scientists found that propranolol significantly reduced lung metastasis in 4T1 murine breast cancer cells. In vitro and in vivo experiments demonstrated that propranolol inhibited the epithelial–mesenchymal transition as evidenced by Western Blot analysis.